Back
Adaptimmune Therapeutics PLC Stock Price Chart
Sponsored
ADAP
Sponsored
"The Next Apple?" - Mode's Growth Story is Turning Heads
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
23
ADAP
Adaptimmune Therapeutics PLC
Last Price:
1.04
Seasonality Move:
-31.44%
7 Day Trial
ALL ACCESS PASS
$
7
Hedge fund manager warns about the market ahead
Free book prepares you for the coming uncertainty in the stock market- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADAP is experiencing slight selling pressure.
Adaptimmune Therapeutics PLC Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.08 | Sell |
20-day SMA: | 1.16 | Sell |
50-day SMA: | 1.16 | Sell |
200-day SMA: | 1.09 | Sell |
8-day EMA: | 1.08 | Sell |
20-day EMA: | 1.12 | Sell |
50-day EMA: | 1.13 | Sell |
200-day EMA: | 1.1 | Sell |
Adaptimmune Therapeutics PLC Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.03 | Sell |
Relative Strength Index (14 RSI): | 40.8 | Sell |
Chaikin Money Flow: | -191017 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.06 - 1.22) | Sell |
Bollinger Bands (100): | (0.99 - 1.23) | Sell |
Adaptimmune Therapeutics PLC Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Adaptimmune Therapeutics PLC Stock
Is Adaptimmune Therapeutics PLC Stock a Buy?
- Adaptimmune Therapeutics PLC share price is 1.04 while ADAP 8-day simple moving average is 1.08, which is a Sell signal.
- The stock price of ADAP is 1.04 while Adaptimmune Therapeutics PLC 20-day SMA is 1.16, which makes it a Sell.
- Adaptimmune Therapeutics PLC 50-day simple moving average is 1.16 while ADAP share price is 1.04, making it a Sell technically.
- ADAP stock price is 1.04 and Adaptimmune Therapeutics PLC 200-day simple moving average is 1.09, creating a Sell signal.
ADAP Technical Analysis vs Fundamental Analysis
Sell
23
Adaptimmune Therapeutics PLC (ADAP)
is a Sell
Is Adaptimmune Therapeutics PLC a Buy or a Sell?
-
Adaptimmune Therapeutics PLC stock is rated a Sell
The current Adaptimmune Therapeutics PLC [ADAP] share price is $1.04. The Score for ADAP is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
Adaptimmune Therapeutics PLC Stock Info
Market Cap:
265.98M
Price in USD:
1.04
Share Volume:
955.09K
Adaptimmune Therapeutics PLC 52-Week Range
52-Week High:
2.05
52-Week Low:
0.42
Sell
23
Adaptimmune Therapeutics PLC (ADAP)
is a Sell
Adaptimmune Therapeutics PLC Share Price Forecast
-
What is the Adaptimmune Therapeutics PLC stock price today?
The Adaptimmune Therapeutics PLC stock price is 1.04 USD today. -
Will ADAP stock go up or go down?
Adaptimmune Therapeutics PLC> share price is forecast to RISE/FALL based on technical indicators -
Is Adaptimmune Therapeutics PLC overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Adaptimmune Therapeutics PLC is overvalued.
Is Adaptimmune Therapeutics PLC Stock a Buy?
- Adaptimmune Therapeutics PLC share price is 1.04 while ADAP 8-day exponential moving average is 1.08, which is a Sell signal.
- The stock price of ADAP is 1.04 while Adaptimmune Therapeutics PLC 20-day EMA is 1.12, which makes it a Sell.
- Adaptimmune Therapeutics PLC 50-day exponential moving average is 1.13 while ADAP share price is 1.04, making it a Sell technically.
- ADAP stock price is 1.04 and Adaptimmune Therapeutics PLC 200-day simple moving average is 1.10, creating a Sell signal.
Fundamental Analysis of Adaptimmune Therapeutics PLC
Is Adaptimmune Therapeutics PLC a good investment?
- Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.22 per share, and a decrease next year of $0.34 per share.
Technical Analysis of Adaptimmune Therapeutics PLC
Should I short Adaptimmune Therapeutics PLC stock?
- ADAP Moving Average Covergence Divergence (MACD) indicator is -0.03, suggesting Adaptimmune Therapeutics PLC is a Sell
- Adaptimmune Therapeutics PLC Relative Strength Index (RSI) is 40.8, which suggest Adaptimmune Therapeutics PLC is oversold
- The Bollinger Bands (25) for Adaptimmune Therapeutics PLC is (1.06 - 1.22), which suggest Adaptimmune Therapeutics PLC is a Sell
- The Bollinger Bands (100) for Adaptimmune Therapeutics PLC is (0.99 - 1.23), which suggest Adaptimmune Therapeutics PLC is a Sell
* Adaptimmune Therapeutics PLC stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.